Should I Take Aspirin to Prevent Cancer?

PF_pillsFinal_100SMALL

A steady drumbeat of research suggest that taking a small dose of daily aspirin over a period of years can reduce the risk of certain cancers. In August, researchers from London’s Queen Mary University concluded that daily aspirin taken over 10 years reduced the risk of developing cancers of the digestive tract – colon, stomach, and esophagus – by as much as 40 percent, and had a lesser impact on the number of lung, breast and prostate cancer diagnoses. The leader of the research – published in the Annals of Oncology,  said “the evidence is that everyone between 50 and …

Continue reading

Brain Tumor Survivor Shares Her Tips on the College Transition

Frannie 2_SMALL

By Frannie Palmer As a kid, I stumbled on my feet quite a bit. I had to use two hands on the railing while going down stairs. My parents thought I was just a little clumsy. The truth was, a brain tumor was creating pressure on my cerebellum and causing my incoordination. I was 6-years-old when I had surgery to remove the non-cancerous tumor. It wasn’t until I began applying for early decision admission to Wheaton College that I fully grasped how much it had affected me. After the surgery, I had to re-learn how to walk and talk. My …

Continue reading

New Drug Combination Shows Promise for Women with Recurrent Ovarian Cancer

SOG_5642_10_SMALL

For many women with ovarian cancer that has returned after initial treatment, a two-drug combination can significantly extend the time that the disease is kept in check, according to a phase 2 clinical trial led by investigators at the Susan F. Smith Center for Women’s Cancers at Dana-Farber. As reported in Lancet Oncology, researchers compared the drugs cediranib and olaparib, versus olaparib alone, in their ability to stall the advance of ovarian cancer in women with a recurrent form of the disease that responds to platinum-based chemotherapy agents. The investigators found that the median period before the disease began to …

Continue reading

Breast Cancer Survivor Barbara Stinson Turns to Nature and Photography

To most people, a flower is just a flower. To 70-year-old Barbara Stinson, flowers represent beauty, energy and positivity. A two-time breast cancer survivor, she has combined her passions of gardening and photography in her new book, “PINK PETALS: A Focus on Healing through a Gallery of Flowers.” Each of the 80 pages of the book features an intimate photograph of a pink flower – a color, she says once was a mere fashion choice, but now has taken on a whole new meaning. Each picture is accompanied by an inspirational passage, which links artistic details of the flower to life …

Continue reading

What are Merkel Cells?

Because long-term exposure to sunlight is considered a risk factor for Merkel cell carcinoma, it’s important to limit your exposure to UV rays.

Merkel cells are found just below your skin’s surface, on the lowest level of your top layer of skin (the epidermis). Connected to nerve endings associated with the sensation of touch, Merkel cells play a key role in helping us identify fine details and textures by touch. A rare and dangerous form of skin cancer known as Merkel cell carcinoma is thought to originate from Merkel cells when they grow out of control. This disease usually appears as a painless skin nodule (lump) that can be skin-colored, red, or violet, most often developing in areas of skin exposed to the …

Continue reading

Five Things Young Women with Breast Cancer Should Know

SOG_9339_12SMALL

While the majority of women diagnosed with breast cancer are age 55 or older, about 14,500 women age 45 and younger are diagnosed with breast cancer in the U.S. each year. In recognition of Breast Cancer Awareness Month, here are some facts about breast cancer all young women should know. 1. Genetic testing can help identify women who are at increased risk While all women are at risk for breast cancer, women who have a family history of premenopausal breast or ovarian cancer or a family member with a mutation in the BRCA1 or BRCA2 gene are at a higher risk and should speak …

Continue reading

The Latest in Ovarian Cancer Treatment and Research

MatulonisSMALL

Although ovarian cancer is often difficult to treat, research continues to yield results that are improving outcomes and quality of life for many patients. “Ovarian cancer research and treatment is exciting today because there are so many resources available and we are no longer committed to just the standard chemotherapy,” says Susana Campos, MD, MPH, a gynecologic oncologist with the Susan F. Smith Center for Women’s Cancers at Dana-Farber. “People can really have fruitful lives even if they are living with ovarian cancer.” Campos recently joined fellow gynecologic oncologist Panos Konstantinopoulos, MD, PhD, for a live video webchat led by …

Continue reading

What are the Different Types of Non-Hodgkin Lymphoma?

SOG_4567_13SMALL

Although lymphoma diagnoses are often categorized as either Hodgkin lymphoma or non-Hodgkin lymphoma, there are many subtypes of each disease, with more than 50 subtypes of non-Hodgkin lymphoma alone. Most forms of the more than 70,000 new cases of non-Hodgkin lymphoma diagnosed in the U.S. each year can be broken up into two main subtypes: B-cell lymphomas and T-cell lymphomas. The subtype is based on whether the cancer cells develop in the body’s B-cells or T-cells, which are two forms of white blood cells. The maturity of the B-cell or T-cell also dictates the type of lymphoma that develops. Read …

Continue reading

What is Gestational Trophoblastic Disease?

Donald Goldstein, M.D.SMALL

Gestational Trophoblastic Disease (GTD) is a rare disease where a group of tumors develops in the uterus after conception, leading to abnormal development of the placenta. It affects about 1 in 1,000 pregnancies. More than 80 percent of GTD cases are non-cancerous and all forms can be treated, with the majority of cases curable. Physicians with the New England Trophoblastic Disease Center at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC), affiliated with the Susan F. Smith Center for Women’s Cancers at Dana-Farber, have produced more than 300 original research reports and publications on GTD, which continue to help improve prevention, early …

Continue reading

Marathon Motorcyclists Roll for Dana-Farber

Bikes Fred in Lucky Hat

Like many Dana-Farber Cancer Institute supporters, Fred Georgoulis walked 26.2 miles on Sunday in the Boston Marathon® Jimmy Fund Walk presented by Hyundai. It was Georgoulis’ second trip in recent months down this course; his last was on a classic Harley Davidson FXRS. Georgoulis is the creator and director of the Boston Motorcycle Marathon Ride, one of the Jimmy Fund’s newest events. For the past two summers, on the second Sunday in August, he and more than 1,000 other motorcycle enthusiasts have ridden the legendary Hopkinton-to-Copley Square route of the Boston Marathon® , raising money for research and patient care at Dana-Farber …

Continue reading